Compound Detail
CHEMBL473417
VISMODEGIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL473417 |
| Name | VISMODEGIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | BPQMGSKTAYIVFO-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
130
Targets
676
Activities
4
Assay Types
30
PK Parameters
20
Publications
5
Known Names
20
Indications
1
Mechanisms
Molecular Properties
421.3
MW (Da)
4.71
ALogP
4
HBA
1
HBD
76.1
PSA (Ų)
0.66
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2012 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Smoothened homolog inhibitor | INHIBITOR | Protein smoothened | ✓ | ✓ |
Indications
Carcinoma, Basal Cell Carcinoma, Basal Cell Neoplasms Neoplasms Basal Cell Nevus Syndrome Breast Neoplasms Breast Neoplasms Bronchiolitis Obliterans Syndrome Carcinoma, Pancreatic Ductal Chondrosarcoma, Clear Cell Chondrosarcoma, Mesenchymal Glioblastoma Glioblastoma Gliosarcoma Idiopathic Pulmonary Fibrosis Leukemia, Myeloid, Acute Medulloblastoma Medulloblastoma Meningioma Multiple Myeloma
ATC Classification
L01XJ01
vismodegib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Drug Warnings
Black Box Warning
teratogenicity
Activity Summary
IC50 653 meas. best 9.4
Kd 15 meas. best 7.01
EC50 6 meas. best 8.7
Ki 2 meas. best 7.91
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Protein smoothened CHEMBL5971 | IC50 | 9.4 | 8.004 | 0.4 | 10 |
| Protein smoothened CHEMBL6080 | IC50 | 8.82 | 7.7038 | 1.5 | 8 |
| Protein smoothened CHEMBL5971 | EC50 | 8.7 | 8.61 | 2.0 | 2 |
| Protein smoothened CHEMBL6080 | EC50 | 8.7 | 8.515 | 2.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 8.7 | 6.8076 | 2.0 | 29 |
| Molecular identity unknown CHEMBL612546 | IC50 | 8.64 | 7.736 | 2.3 | 10 |
| Sonic hedgehog protein CHEMBL5387 | IC50 | 8.52 | 8.042 | 3.0 | 5 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 8.4 | 5.8286 | 4.0 | 7 |
| Medulloblastoma cell CHEMBL4296520 | IC50 | 8.33 | 7.925 | 4.7 | 2 |
| C3H 10T1/2 CHEMBL614531 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| Protein smoothened CHEMBL5971 | Ki | 7.91 | 7.85 | 12.2 | 2 |
| Molecular identity unknown CHEMBL612546 | EC50 | 7.89 | 7.89 | 13.0 | 1 |
| Sonic hedgehog protein CHEMBL5602 | IC50 | 7.82 | 6.79 | 15.0 | 2 |
| IGROV-1 CHEMBL613984 | IC50 | 7.14 | 7.14 | 72.5 | 1 |
| Protein smoothened CHEMBL5971 | Kd | 7.01 | 7.01 | 97.5 | 1 |
| HT-29 CHEMBL384 | IC50 | 5.97 | 5.275 | 1080.0 | 2 |
| ADMET CHEMBL612558 | Kd | 5.96 | 5.525 | 1100.0 | 4 |
| HCE-T CHEMBL2366139 | IC50 | 5.88 | 5.88 | 1322.5 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 CHEMBL5393 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| D-542MG CHEMBL2366208 | IC50 | 5.73 | 5.73 | 1867.4 | 1 |
| 23132-87 CHEMBL1075382 | IC50 | 5.36 | 5.36 | 4401.5 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 28 CHEMBL2157853 | IC50 | 5.36 | 5.34 | 4410.0 | 2 |
| Albumin CHEMBL3253 | Kd | 5.26 | 5.24 | 5500.0 | 2 |
| Albumin CHEMBL4817 | Kd | 5.24 | 5.24 | 5800.0 | 1 |
| HDLM-2 CHEMBL2366231 | IC50 | 5.09 | 5.09 | 8047.7 | 1 |
| ACN CHEMBL2366195 | IC50 | 5.07 | 5.07 | 8501.1 | 1 |
| HuO-3N1 CHEMBL1075475 | IC50 | 5.02 | 5.02 | 9601.1 | 1 |
| BHT-101 CHEMBL1075398 | IC50 | 4.94 | 4.94 | 11380.0 | 1 |
| KYSE-150 cell line CHEMBL613998 | IC50 | 4.94 | 4.94 | 11584.1 | 1 |
| MC-IXC CHEMBL1075495 | IC50 | 4.91 | 4.91 | 12229.2 | 1 |
| D-423MG CHEMBL2366134 | IC50 | 4.89 | 4.89 | 12765.7 | 1 |
| NY CHEMBL1075552 | IC50 | 4.83 | 4.83 | 14890.3 | 1 |
| NB7 CHEMBL2366345 | IC50 | 4.8 | 4.8 | 15891.0 | 1 |
| HOS CHEMBL614736 | IC50 | 4.8 | 4.8 | 15671.9 | 1 |
| DMS-273 CHEMBL614034 | IC50 | 4.78 | 4.78 | 16671.3 | 1 |
| MDA-MB-361 CHEMBL614129 | IC50 | 4.76 | 4.76 | 17271.1 | 1 |
| DU-145 CHEMBL613508 | IC50 | 4.74 | 4.74 | 18320.0 | 1 |
| NCI-H82 CHEMBL2366077 | IC50 | 4.7 | 4.7 | 19838.6 | 1 |
| SNU1 CHEMBL614931 | IC50 | 4.7 | 4.7 | 20019.6 | 1 |
| GCT CHEMBL1075448 | IC50 | 4.68 | 4.68 | 20882.4 | 1 |
| C2BBe1 CHEMBL2366283 | IC50 | 4.68 | 4.68 | 21105.8 | 1 |
| LB2241-RCC CHEMBL2366330 | IC50 | 4.66 | 4.66 | 21844.1 | 1 |
| COLO-829 CHEMBL2366275 | IC50 | 4.65 | 4.65 | 22187.1 | 1 |
| EW-11 CHEMBL2366223 | IC50 | 4.64 | 4.64 | 22802.2 | 1 |
| NCI-H526 CHEMBL2366102 | IC50 | 4.63 | 4.63 | 23471.7 | 1 |
| SF-295 CHEMBL614908 | IC50 | 4.62 | 4.62 | 24025.2 | 1 |
| D-566MG CHEMBL2366336 | IC50 | 4.6 | 4.6 | 25294.3 | 1 |
| 8505C CHEMBL1075387 | IC50 | 4.59 | 4.59 | 25633.1 | 1 |
| NBsusSR CHEMBL2366150 | IC50 | 4.57 | 4.57 | 26800.6 | 1 |
| BV-173 CHEMBL2366145 | IC50 | 4.55 | 4.55 | 28318.2 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2455.65 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2500.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2456.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2455.65 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 22403.25 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 4049.8 | ng.hr.mL-1 | Mus musculus |
| AUC | 7657.68 | ng.hr.mL-1 | Mus musculus |
| AUC | 2456.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 3.7 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.4 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 3.7 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.771 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.8 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.767 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.771 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 4.681 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.767 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 5.6 | mL.min-1.kg-1 | Mus musculus |
| CL | 2.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.04 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 19.0 | % | Canis lupus familiaris |
| Cmax | 2966.94 | nM | Rattus norvegicus |
| Cmax | 2848.26 | nM | Rattus norvegicus |
| Cmax | 2966.94 | nM | Rattus norvegicus |
| Cmax | 2966.94 | nM | Rattus norvegicus |
| Cmax | 8637.35 | nM | Rattus norvegicus |
| Cmax | 2027.01 | nM | Mus musculus |
| Cmax | 2966.94 | nM | Rattus norvegicus |
| F | 100.0 | % | Rattus norvegicus |
| F | 33.0 | % | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21438527 | 10.1021/jm1008924 | ADMET | 17 |
| 31862310 | 10.1016/j.bmc.2019.115227 | ADMET | 15 |
| 26820554 | 10.1016/j.ejmech.2016.01.018 | Rattus norvegicus | 13 |
| 28873303 | 10.1021/acs.jmedchem.7b01185 | Unchecked | 12 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 9 |
| 26254279 | 10.18632/oncotarget.4214 | Unchecked | 9 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 8 |
| 24973920 | 10.1038/nm.3613 | Medulloblastoma cell | 7 |
| 21438527 | 10.1021/jm1008924 | Albumin | 7 |
| 32690258 | 10.1016/j.bmc.2020.115584 | ADMET | 7 |
| 31862310 | 10.1016/j.bmc.2019.115227 | Protein smoothened | 6 |
| 24486203 | 10.1016/j.bmc.2013.12.055 | Rattus norvegicus | 6 |
| 27810591 | 10.1016/j.ejmech.2016.10.040 | Unchecked | 6 |
| 35859880 | 10.1021/acsmedchemlett.1c00562 | Unchecked | 6 |
| 24405704 | 10.1016/j.bmcl.2013.12.050 | Rattus norvegicus | 6 |
| 26827136 | 10.1016/j.bmc.2016.01.034 | Rattus norvegicus | 6 |
| 24900716 | 10.1021/ml400014t | Molecular identity unknown | 6 |
| - | 10.6019/CHEMBL5058564 | U2OS | 6 |
| 30471551 | 10.1016/j.ejmech.2018.11.028 | Unchecked | 5 |
| 29929879 | 10.1016/j.bmcl.2018.06.025 | Mus musculus | 5 |
Data from ChEMBL 36 via Core Engine